Dasol Oh
Papers
1
Total Citations
8
H-Index
1
About
Dasol Oh is a pioneering gynecologic oncologist whose research focuses on advancing minimally invasive surgical techniques for the treatment of gynecologic cancers. Her major contributions center on evaluating the feasibility, safety, and efficacy of novel surgical platforms, particularly the ArtiSential articulating instrument system, in complex oncologic procedures. Oh led the landmark KGOG 4002/GYANT study, a prospective multicenter trial across 10 tertiary hospitals in Korea, which demonstrated that ArtiSential-assisted surgery is both safe and effective for early-stage gynecologic cancer, offering enhanced dexterity and precision. This work, published in 2024 and already garnering 8 citations, has significant implications for expanding access to less invasive treatment options. Oh’s research is instrumental in shaping modern surgical standards, reducing recovery times, and improving patient outcomes. Her dedication to rigorous clinical investigation and innovation in surgical oncology positions her as a rising leader in the field, with her findings poised to influence practice guidelines and inspire further technological adoption in gynecologic cancer care.
Research Focus
Key Achievements
Top Papers
- 1